Sign in
Not yet taking people in NetherlandsPhase 4

Iron infusion for people with aortic stenosis having valve replacement

Tests ferric carboxymaltose in people with aortic stenosis and low iron.

Key facts

Who runs it
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Where
Rotterdam, NetherlandsSee the site
Registry title
Iron Infusion in Elderly Patients undergoing Transcatheter Aortic Valve Implantation (IRON TAVI) Trial
Status
Not yet recruiting
Phase
Phase 4
People taking part
378 people, planned
Started
15 Jan 2024
Expected to end
31 Dec 2028
Type of study
Interventional
Record updated
12 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 65 or older with severe aortic stenosis and iron deficiency who had a successful TAVI. TAVI is a valve replacement done through a tube in a blood vessel. The trial tests iron given into a vein (ferric carboxymaltose).

Age
65 years or older (the record also lists a minimum age of 18 Years).
Sex
All sexes can join.
Disease stage
Severe aortic stenosis (narrowed heart valve), with a successful TAVI already done.
Earlier treatment
Must have had a successful TAVI. Cannot join after erythropoietin, iron by vein or mouth, or a blood transfusion in the previous 3 months, or if these are planned within the next 6 months.
Biomarker or test result
Iron deficiency: serum iron ≤13 μmol/L and/or transferrin saturation ≤20%. Ferritin must not be > 400 ug/L. Hemoglobin must not be <5.6 mmol/L or <9 g/dL, nor >8.7 mmol/L or >14 g/dL in men and >8.1 mmol/L or >13 g/dL in women.

Main reasons for not taking part

  • Infection that needs antibiotics, or allergy to iFCM
  • Pregnancy
  • Anaemia from other causes, such as blood or bone marrow disease, active cancer or ongoing bleeding
  • Chronic liver disease, or liver tests above three times the upper limit of normal
  • Dialysis (past, current or planned within 6 months), eGFR <15 mL/min, or past iron overload

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Patient age ≥ 65 years
  • Patients with severe aortic stenosis and iron deficiency undergoing successful TAVI
  • Iron deficiency defined as serum iron ≤13 μmol/L and/or transferrin saturation ≤20%
  • Ability to perform assessment of quality of life (questionnaire assessment), exercise capacity (6-minute walk test) and cognitive function assessment (questionnaire assessment)
  • Signed Informed Consent

Who cannot take part

  • Renal dialysis (previous, current, or planned within the next 6 months) or MDRD/CKD-EPI estimated glomerular filtration rate <15 mL/min
  • History of erythropoietin, i.v. or oral iron therapy, and blood transfusion in previous 3 months and/or such therapy planned within next 6 months
  • Clinically apparent infection requiring antibiotic treatment
  • Known hypersensitivity to iFCM or to any of its excipients
  • Study subject participation in another TAVI related clinical study in which the primary endpoint includes mortality, hospitalization for heart failure and/or quality of life assessment
  • Anaemia due to known reasons other than ID and/or anticipated non-response to iron-supplementation (e.g. hemogobinopathy, bone marow disease, active cancer, unresolved active bleeding)
  • History of iron overload
  • Hemoglobin <5.6 mmol/L or <9 g/dL
  • Hemoglobin >8.7 mmol/L or >14 g/dL in men and >8.1 mmol/L or >13 g/dL in women
  • Chronic liver disease (including active hepatitis) and/or screening alanine transaminase or aspartate transaminase above three times the upper limit of the normal range
  • Contra-indication for transfemoral TAVI
  • Pregnancy
  • Ferritin > 400 ug/L

Where in Netherlands

  • Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Rotterdam, NetherlandsNot yet recruiting

About the trial

What the trial wants to find out

To determine whether intravenous iron (ferric carboxymaltose) would improve Quality of life and Exercise Capacity in patients with severe Aortic Stenosis and Iron Deficiency undergoing TAVI

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Iron Infusion in Elderly Patients undergoing Transcatheter Aortic Valve Implantation (IRON TAVI) Trial
Plain-language title
Iron infusion for people with aortic stenosis having valve replacementGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 November 2026